Variant Gene Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs4691139
rs4691139
0.810 GeneticVariation GWASCAT Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. 28346442

2017

dbSNP: rs1243180
rs1243180
0.810 GeneticVariation BEFREE We genotyped two tightly linked single-nucleotide polymorphisms (SNPs) at MLLT10 associated with meningioma (rs12770228) or ovarian cancer (rs1243180), and tested for associations among 295 meningioma cases, 606 glioma cases and 646 noncancer controls, all of European descent. 24755950

2015

dbSNP: rs10088218
rs10088218
0.810 GeneticVariation GWASCAT GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. 23535730

2013

dbSNP: rs10088218
rs10088218
0.810 GeneticVariation GWASDB GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. 23535730

2013

dbSNP: rs1243180
rs1243180
0.810 GeneticVariation GWASDB GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. 23535730

2013

dbSNP: rs1243180
rs1243180
0.810 GeneticVariation GWASCAT GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. 23535730

2013

dbSNP: rs17631303
rs17631303
0.810 GeneticVariation GWASCAT Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. 23544013

2013

dbSNP: rs17631303
rs17631303
0.810 GeneticVariation BEFREE In addition, we identified two novel ovarian cancer risk modifier loci: 17q21.31 (rs17631303, P = 1.4 × 10(-8), HR = 1.27, 95% CI: 1.17-1.38) and 4q32.3 (rs4691139, P = 3.4 × 10(-8), HR = 1.20, 95% CI: 1.17-1.38). 23544013

2013

dbSNP: rs17631303
rs17631303
0.810 GeneticVariation GWASDB Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. 23544013

2013

dbSNP: rs3814113
rs3814113
0.810 GeneticVariation GWASCAT Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. 23544013

2013

dbSNP: rs3814113
rs3814113
0.810 GeneticVariation GWASDB Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. 23544013

2013

dbSNP: rs3814113
rs3814113
0.810 GeneticVariation GWASDB GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. 23535730

2013

dbSNP: rs3814113
rs3814113
0.810 GeneticVariation GWASCAT GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. 23535730

2013

dbSNP: rs4691139
rs4691139
0.810 GeneticVariation GWASDB Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. 23544013

2013

dbSNP: rs4691139
rs4691139
0.810 GeneticVariation BEFREE In addition, we identified two novel ovarian cancer risk modifier loci: 17q21.31 (rs17631303, P = 1.4 × 10(-8), HR = 1.27, 95% CI: 1.17-1.38) and 4q32.3 (rs4691139, P = 3.4 × 10(-8), HR = 1.20, 95% CI: 1.17-1.38). 23544013

2013

dbSNP: rs4691139
rs4691139
0.810 GeneticVariation GWASCAT Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. 23544013

2013

dbSNP: rs9303542
rs9303542
0.810 GeneticVariation GWASDB GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. 23535730

2013

dbSNP: rs9303542
rs9303542
0.810 GeneticVariation GWASCAT GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. 23535730

2013

dbSNP: rs10088218
rs10088218
0.810 GeneticVariation BEFREE Two loci were associated with ovarian cancer risk in BRCA1 carriers; rs10088218 per-allele HR = 0.89 (95% CI: 0.81-0.99) P-trend = 0.029, rs2665390 HR = 1.25 (95% CI: 1.10-1.42) P-trend = 6.1 × 10(-4). 22253144

2012

dbSNP: rs2665390
rs2665390
0.810 GeneticVariation BEFREE Two loci were associated with ovarian cancer risk in BRCA1 carriers; rs10088218 per-allele HR = 0.89 (95% CI: 0.81-0.99) P-trend = 0.029, rs2665390 HR = 1.25 (95% CI: 1.10-1.42) P-trend = 6.1 × 10(-4). 22253144

2012

dbSNP: rs9303542
rs9303542
0.810 GeneticVariation BEFREE All four loci were associated with ovarian cancer risk in BRCA2 carriers; rs10088218 per-allele hazard ratio (HR) = 0.81 (95% CI: 0.67-0.98) P-trend = 0.033, rs2665390 HR = 1.48 (95% CI: 1.21-1.83) P-trend = 1.8 × 10(-4), rs717852 HR = 1.25 (95% CI: 1.10-1.42) P-trend = 6.6 × 10(-4), rs9303542 HR = 1.16 (95% CI: 1.02-1.33) P-trend = 0.026. 22253144

2012

dbSNP: rs3814113
rs3814113
0.810 GeneticVariation BEFREE BRCA1 mutation carriers with the TT genotype at SNP rs3814113 were predicted to have an ovarian cancer risk to age 80 years of 48%, and those with the CC genotype were predicted to have a risk of 33%. 21169536

2011

dbSNP: rs10088218
rs10088218
0.810 GeneticVariation GWASDB A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. 20852632

2010

dbSNP: rs10088218
rs10088218
0.810 GeneticVariation GWASCAT A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. 20852632

2010

dbSNP: rs2665390
rs2665390
0.810 GeneticVariation GWASDB A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. 20852632

2010